Published in Infect Immun on December 01, 2003
Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol (2006) 3.43
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 2.28
The copper regulon of the human fungal pathogen Cryptococcus neoformans H99. Mol Microbiol (2011) 1.08
Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist. Haematologica (2009) 0.90
Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study. Haematologica (2012) 0.83
Vibrio Iron Transport: Evolutionary Adaptation to Life in Multiple Environments. Microbiol Mol Biol Rev (2015) 0.83
Hepcidin is an antibacterial, stress-inducible peptide of the biliary system. PLoS One (2011) 0.80
Effect of iron-chelator deferiprone on the in vitro growth of staphylococci. J Korean Med Sci (2009) 0.79
Endotoxin binding by sevelamer: potential impact on nutritional status. Int J Nephrol (2013) 0.78
Hepcidin - A novel biomarker with changing trends. Pharmacogn Rev (2015) 0.77
Immune Dysfunction in Cirrhosis. J Clin Transl Hepatol (2017) 0.75
Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem (2000) 8.52
Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem (2000) 8.39
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood (2002) 7.58
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev (1998) 5.78
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A (2001) 5.77
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett (2000) 5.22
Cholera and other vibrioses in the United States. N Engl J Med (1985) 5.17
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood (2003) 5.11
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A (2002) 4.64
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet (2003) 4.49
Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun (1981) 4.42
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet (2002) 4.19
Iron and oxidative stress in bacteria. Arch Biochem Biophys (2000) 4.00
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 3.93
Clinical features and an epidemiological study of Vibrio vulnificus infections. J Infect Dis (1984) 3.69
Isolation and characterization of Vibrio vulnificus from two Florida estuaries. Appl Environ Microbiol (1982) 3.58
Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect (2000) 3.10
Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun (1985) 2.48
The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group. J Infect Dis (1998) 2.46
Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect (1999) 2.46
Pathogenesis of Vibrio vulnificus. FEMS Microbiol Lett (1999) 2.32
Vibrio infections on the Gulf Coast: results of first year of regional surveillance. Gulf Coast Vibrio Working Group. J Infect Dis (1993) 2.30
Acquisition of siderophores in gram-negative bacteria. Nat Rev Mol Cell Biol (2003) 2.24
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest (1988) 2.18
The Yersinia deadly kiss. J Bacteriol (1998) 2.03
Evidence for the presence of a capsule in Vibrio vulnificus. J Gen Microbiol (1984) 1.94
Effect of iron on the bactericidal proteins from rabbit polymorphonuclear leukocytes. Nature (1970) 1.91
The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice. Infect Immun (1991) 1.87
The Yersinia high-pathogenicity island: an iron-uptake island. Microbes Infect (2001) 1.79
Role of catechol siderophore synthesis in Vibrio vulnificus virulence. Infect Immun (1996) 1.78
Nitric oxide and the regulation of gene expression. Trends Cell Biol (2001) 1.76
Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology (1984) 1.73
Vibrio vulnificus--a new monster of the deep? Ann Intern Med (1988) 1.71
Ferrioxamine uptake in Yersinia enterocolitica: characterization of the receptor protein FoxA. Mol Microbiol (1992) 1.68
Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med (1991) 1.65
Iron and immunity: a double-edged sword. Eur J Clin Invest (2002) 1.60
The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded mice. Infect Immun (1998) 1.55
Microbial siderophore-mediated transport. Biochem Soc Trans (2002) 1.55
Metalloprotease is not essential for Vibrio vulnificus virulence in mice. Infect Immun (2000) 1.48
Multiple liver abscesses due to Yersinia enterocolitica discloses primary hemochromatosis: three cases reports and review. Clin Infect Dis (1994) 1.44
Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice. Infect Immun (2000) 1.42
Structural biology of bacterial iron uptake systems. Curr Top Med Chem (2001) 1.37
Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem (2002) 1.37
Incidence of Vibrio species associated with blue crabs (Callinectes sapidus) collected from Galveston Bay, Texas. Appl Environ Microbiol (1982) 1.35
Vibrio vulnificus. Man and the sea. JAMA (1985) 1.35
Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect Immun (1985) 1.35
Construction and phenotypic evaluation of a Vibrio vulnificus vvpE mutant for elastolytic protease. Infect Immun (2000) 1.34
Cloning and characterization of an outer membrane protein of Vibrio vulnificus required for heme utilization: regulation of expression and determination of the gene sequence. Infect Immun (1998) 1.32
Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut (1997) 1.27
Iron loading and disease surveillance. Emerg Infect Dis (1999) 1.26
Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect Immun (1999) 1.24
Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med (1994) 1.24
Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin. Infect Immun (2001) 1.22
Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect Immun (1999) 1.20
Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect Immun (1983) 1.20
Mechanisms of solute transport through outer membrane porins: burning down the house. Curr Opin Microbiol (1998) 1.19
Genetics of haemochromatosis. Lancet (2002) 1.18
Transferrin-iron uptake by Gram-negative bacteria. Front Biosci (2003) 1.18
Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp Hematol (1992) 1.17
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun (1997) 1.15
Effects of iron overload on the immune system. Ann Clin Lab Sci (2000) 1.13
Cloning and characterization of vuuA, a gene encoding the Vibrio vulnificus ferric vulnibactin receptor. Infect Immun (2000) 1.12
Microbial pathogens with impaired ability to acquire host iron. Biometals (2000) 1.08
Physiological effects of the lipopolysaccharide of Vibrio vulnificus on mice and rats. Microbios (1991) 1.03
Host factors causing increased susceptibility to infection in patients with Laennec's cirrhosis. Ann N Y Acad Sci (1975) 1.03
Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol (2002) 1.03
Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum. Microbiol Immunol (1987) 1.00
Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br Med J (Clin Res Ed) (1982) 0.99
Identification and expression analysis of hepcidin-like antimicrobial peptides in bony fish. Dev Comp Immunol (2003) 0.98
Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J Infect Dis (1991) 0.93
Functional defects in phagocytic cells from patients with iron overload. J Infect (1984) 0.93
Haemochromatosis presenting with a double Yersinia infection. J Infect (1986) 0.89
Modulation of intramacrophage iron metabolism during microbial cell invasion. Microbes Infect (2000) 0.88
Hemochromatosis and infection: alcohol and iron, oysters and sepsis. Am J Med (1989) 0.87
Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood (1998) 0.85
Multiple hepatic abscesses due to Yersinia enterocolitica. Pathology (1995) 0.85
Vibrio vulnificus hazard in patients with liver disease. West J Med (1994) 0.84
Recurrent bacterial peritonitis caused by Neisseria cinerea in a chronic ambulatory peritoneal dialysis (CAPD) patient. Diagn Microbiol Infect Dis (1996) 0.81
Fatal Listeria meningitis, endocarditis and pericarditis in a patient with haemochromatosis. Scand J Infect Dis (1997) 0.80
Yersinia enterocolitis in iron overload. J Pediatr Gastroenterol Nutr (1988) 0.79
Ferric-reductase activities in Vibrio vulnificus biotypes 1 and 2. FEMS Microbiol Lett (1999) 0.78
Iron and lymphocytes: reciprocal regulatory interactions. Curr Stud Hematol Blood Transfus (1991) 0.78
A functional defect in hereditary haemochromatosis monocytes and monocyte-derived macrophages. Eur J Clin Invest (1998) 0.78
Overwhelming gram negative septic shock in haemochromatosis. Anaesth Intensive Care (1995) 0.76
A fatal case of Vibrio vulnificus presenting as septic arthritis. Arch Intern Med (2001) 0.76
Yersinia enterocolitica liver abscesses unmasking idiopathic hemochromatosis. J Clin Gastroenterol (1994) 0.76